Australia's Immunisation Crisis: A Call to Action for GPs
Australia is facing a critical moment in its vaccination journey, with plummeting rates and a rising risk of disease outbreaks. But here's where it gets controversial: the solution might lie in the trusted relationship between GPs and their patients.
The Australian Technical Advisory Group on Immunisation (ATAGI) has identified a concerning decline in immunisation rates, particularly post-COVID-19, and a record flu season in 2025. Experts are urging GPs to take action, advocating for an 'opportunistic review' of patients' vaccination status during consultations. But why is this so important?
The issue is twofold. Firstly, the decrease in immunisation has led to a heightened risk of measles cases and outbreaks, with the highest pertussis rates since the pandemic. Secondly, there's a growing number of under-vaccinated Australians, especially children, who are now at high risk. And this is the part most people miss: the MMR catch-up vaccination is now funded for all adults born from 1966 with less than two doses, and infants over six months traveling internationally can also receive an additional MMR dose.
ATAGI's November meeting highlighted the impact of influenza, with over 470,000 cases reported this year, the highest ever. They anticipate that the intranasal FluMist, available in 2026, could be a game-changer for young Australians. Meanwhile, the Australian Medical Association's (AMA) report, 'From Coverage to Concern', echoes these worries, labeling Australia's situation as a 'critical juncture' and emphasizing the pivotal role of GPs.
Dr. Danielle McMullen, GP and AMA President, believes GPs are key to turning the tide. She said, 'GPs are trusted community figures who can encourage vaccination.' Dr. Michael Tam, a member of the RACGP Expert Committee, agrees, stating that GPs have always been central to Australia's immunisation strategy. He added, 'GPs and their teams, especially primary care nurses, are often the best source of vaccine information for patients.'
Dr. Tam also highlights the importance of practice nurses in immunisation, a role currently lacking specific funding. He argues that continuity of care is vital, as it allows GPs to address acute health issues while also promoting preventive measures, such as flu immunisation for asthmatic children.
Interestingly, Dr. Tam suggests that vaccine hesitancy is not the sole reason for the decline in immunisation rates. He proposes that increasing poverty and income inequality might be practical barriers, making healthcare financially inaccessible for many. This interpretation adds a layer of complexity to the issue, sparking potential debate.
As Australia's vaccine manufacturing capabilities expand with the opening of a new facility, the focus on national immunisation rates remains crucial. The question is, will GPs be able to help reverse these trends and ensure a healthier future for all Australians? What do you think? Is the solution as simple as leveraging the GP-patient relationship, or are there deeper systemic issues at play?
